Personal Track Record
This is not an investment model
- It is a record of a member’s personal broker account as reported to Covestor
- It cannot be mirrored
Jul 27, 2011
Chris Camillo - View Profile
Personal Track Record
| Inception date | April 22, 2008 |
| Long/Short | Long only |
| Cap bias | Small cap |
| Holding Period | Short term |
Performance and Risk
Performance Summary (as at end of February 09, 2012)
| Inception April 22, 2008 | Member | S&P 500 |
|---|---|---|
| Month to date (%) | 16.75 | 4.41 |
| 3 month (%) | 11.93 | 4.76 |
| 1 year (%) | -14.31 | 2.09 |
| Annualized since inception (%) | 81.80 | 0.68 |
| Since inception (%) | 858.19 | n/a |
| Sharpe (annualized) | 1.18 | 0.01 |
| % of positive months | 65.22 | 60.81 |
Past performance is not indicative of future performance
Commentary - Latest Posts
-
Target’s (TGT) Missoni collection sells out in just 2 hours. September 13, 2011
Just 2 hours post launch, the entire Missoni limited-edition Collection at our local
Target (400 pieces – largest in company history) is sold out. Every single piece. Reported lines of 100pp+ across stores in the DFW area. A big pre-holiday season win for TGT. Laughingatwallstreet.com
FIRST HAND RETAIL CHANNEL CHECK, TARGET 212 MEDALLION SHP CTR, DALLAS TX. 10:00 AM
-
Last day to enter investment story contest ($1,000 cash prize) March 15, 2010
If you haven't already done so, there's still time to submit your real investing story in the contest I am sponsoring for a chance to win up to $1,000 + 5 years Premium Membership to InvestorVillage. Winners' stories may also appear in my upcoming book, The Backyard Investor. The book is on track to be published early next year by St. Martin's Press.
If you have a real-life investment story you think is worthy of sharing with the rest of the investing world (and almost every self-directed...... -
When Valuing Delcath (DCTH), Don’t Forget the Chemo Multiplier March 11, 2010
Over the coming weeks Delcath (DCTH) will release long awaited phase III data on its Percutaneous Hepatic Perfusion ("PHP") System, a minimally invasive, repeatable platform technology to treat cancer using ultra-targeted doses of highly concentrated chemotherapy. It’s a novel, yet easy to understand procedure that employs catheter balloons to isolate the patient’s liver chamber. Ultra high doses of chemotherapy are injected into the sealed liver chamber, manually extracted through the......
-
Delcath (DCTH) – The biotech you will be talking about in 2010 October 14, 2009
I typically avoid development stage, "lottery ticket" style biotech investments – the one exception being when I am presented with a window of visibility into the company’s success during their FDA clinical trials. Medical device companies that perform operations as part of their clinical trials occasionally offer such visibility. The very existence of the Internet makes it difficult to keep news of a life saving procedure on the down low – even more so when that procedure involves a cure for......
- Job Title VP, Partner Development
- Industry Market Research
- Expertise 10-20 years
- Education BBA Finance, Southern Methodist University
- Year of Birth 1974
- Country United States
- State Texas
Follow investment models for free
Start FREE Trial - Create Mirroring AccountImportant Information
- Past performance is no guarantee of future results.
- Performance of a Personal Track Record is calculated by Covestor on a daily time-weighted basis of equity positions in the account provided by the member. It is exclusive of any commissions, fees, dividends, earnings distributions, and cash in the portfolio.
- Month to Date returns and Since Inception returns are revised daily. All other returns (month, 3 month, year to date, et al) are calculated as of the most recent month end date.
- All graph data is as of the end of day for the referenced period, unless otherwise specified.
- Benchmark returns have been calculated by Covestor using a time-weighted calculation of daily index valuations and do not include cash, dividends and earnings distributions, or transaction costs. More
- All Personal Track Record information including personal data, profiles, strategies, commentary, and historical results outside of Covestor has been provided by the Member. Covestor makes no representation or warranty of its accuracy, completeness or relevance and it does not represent the opinions of Covestor.